Intrinsic Value of S&P & Nasdaq Contact Us

IDEXX Laboratories, Inc. IDXX NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
71/100
5/7 Pass
SharesGrow Intrinsic Value
$394.53
-32.4%
Analyst Price Target
$784.38
+34.3%

Stock Statistics — IDXX

IDEXX Laboratories, Inc. (IDXX) has a market capitalization of $46.5B and trades at $584.05. The 52-week range is 356.14-769.98.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 44.3, Earnings Per Share (EPS) of $13.17, annual revenue of $4.3B.

The stock has a beta of 1.72, operates in the Healthcare sector.

Trading Data
Current Price$584.05
52-Week Range356.14-769.98
Volume412.97K
Avg Volume (30D)531.86K
Market Cap$46.5B
Beta (1Y)1.72
Company
IPO Date1991-06-21
Employees11,000
CEOJonathan J. Mazelsky
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS45168D1046
CUSIP45168D104
Income (Latest Year)
Revenue$4.3B
Gross Profit$2.66B
EBITDA$1.47B
Operating Income$1.36B
Net Income$1.06B
EPS$13.17
EPS Diluted$13.08
Shares Outstanding$80.1M
Balance Sheet (Latest Year)
Total Assets$3.35B
Current Assets$1.34B
Cash & ST Investments$180.07M
Total Liabilities$1.75B
Total Debt$1.08B
Net Debt$897.14M
Total Equity$1.61B
Debt / Equity0.67
Valuation Ratios
P/E Ratio44.3
P/S Ratio10.81
P/B Ratio28.97
EV/EBITDA (approx)31.7
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message